abstract |
The invention concerns compounds of the General Formula (I), the compounds can be prepared by conventional methods per se and can be used to treat a human or animal subject suffering from a serotonin-related disorder. The invention also concerns the use, as well as pharmaceutical compositions comprising a compound of formula (I). |